Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
Encrypt Messages
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by TAKEDA PHARMS USA
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
020406
PREVACID
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
021073
ACTOS
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
021428
PREVACID
New Drug Application
Approval
New formulation
(S) Standard review drug
021782
ROZEREM
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
021842
ACTOPLUS MET
New Drug Application
Approval
New combination
(S) Standard review drug
021856
ULORIC
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
021925
DUETACT
New Drug Application
Approval
New combination
(S) Standard review drug
022024
ACTOPLUS MET XR
New Drug Application
Approval
New formulation
(S) Standard review drug
022271
NESINA
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
022287
DEXILANT
New Drug Application
Approval
New ester, new salt, or other noncovalent derivative
(S) Standard review drug
022352
COLCRYS
New Drug Application
Approval
Drug already marketed, but without an approved NDA
(P) Priority review drug
022426
OSENI
New Drug Application
Approval
New combination
(S) Standard review drug
050757
PREVPAC
New Drug Application
Approval
New combination
(S) Standard review drug
125476
ENTYVIO
Biologic License Application
Approval
202799
OMONTYS
OMONTYS PRESERVATIVE FREE
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
203414
KAZANO
New Drug Application
Approval
New combination
(S) Standard review drug
204447
TRINTELLIX
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
208056
DEXILANT SOLUTAB
New Drug Application
Approval
New formulation
(S) Standard review drug
Back to Companies who have applied for FDA Drug Approval